Eligibility self-check

Is OncoBreast21 right for you?

If you've been diagnosed with early-stage breast cancer and completed treatment, answer a few questions to see whether this genomic recurrence test may be suitable for you. Takes about two minutes.

About you

Name (optional)

Age

Contact number

Doctor's name

About your diagnosis

Nature of the tumour

Malignant Benign

Type of tumour

Invasive In-situ (non-invasive)

Stage of breast cancer

Stage I Stage II Stage III

Lymph node status

Negative Positive

Hormonal & receptor status

You'll find these on your biopsy / IHC pathology report.

Estrogen receptor (ER)

Positive Negative

Progesterone receptor (PR)

Positive Negative

HER2

Positive Negative

Menopausal status

Pre-menopausal Post-menopausal

Treatment & sample

Initial therapy received — select all that apply

Adjuvant (endocrine) Chemotherapy Radiotherapy None yet

Tumour tissue (FFPE block) for testing

Available Not available

Please complete the highlighted questions so we can assess your suitability.

As per your clinical inputs

Please consult your Medical Oncologist for further recommendations on the test, or reach out to us for guidance.

Reach out on WhatsApp Email us

For more details, call +91 78939 93388 or +91 88855 66355

Disclaimer

Please consult your Medical Oncologist for further recommendations, or reach out to us at oncobreast21@gmail.com for guidance.
Oncobreast²¹ is neither a screening test not a diagnostic test for breast cancer.
It is performed after a diagnosis of breast cancer to assess recurrence risk and help to determine the most appropriate adjuvant treatment strategy.

www.oncobreast21.com · Disclaimer & Medical Notice